K. Westenfelder, B. Lentes, J. Rackerseder, N. Navab, J. Gschwend, M. Eiber, C. R. Maurer, Jr. Gallium-68 HBED-CC-PSMA Positron Emission Tomography/Magnetic Resonance Imaging for Prostate Fusion Biopsy Clinical genitourinary cancer, August 2018, Volume 16, Issue 4, Pages 245-247 (bib)
	We report on a 62 year-old male patient who presented at our hospital for a second opinion 2 with a rising PSA level of 23 ng/dl. He already underwent two transrectal biopsies (2013 and 3 2015) of the prostate and also a transurethral resection of the prostate (2016) with benign 4 results in histology reports. The patient underwent hybrid imaging of the prostate consisting 5 of multiparametric magnetic resonance imaging (mpMR) in combination with positron 6 emission tomography (PET) utilizing a specific tracer directed against the prostate-specific 7 membrane antigen (PSMA; 68Ga-HBED-CC-PSMA) for further evaluation. Imaging revealed 8 a PI-RADS 4 lesion with strong PSMA positivity on the left anterior lobe (Fig. 1). A transrectal 9 PSMA PET/MR fusion biopsy of the prostate with 4 targeted and 12 random biopsies was 10 performed in local anesthesia in an outpatient setting. As fusion biopsy systems ...
	This material is presented to ensure timely dissemination of scholarly and technical work. Copyright and all rights therein are retained by authors or by other copyright holders. All persons copying this information are expected to adhere to the terms and constraints invoked by each authors copyright. In most cases, these works may not be reposted without the explicit permission of the copyright holder.